MTOR and urinary bladder carcinoma: Our data demonstrated that all of the CWS-loaded formulations, including CWS, inhibited the growth of bladder cancer cells through mTOR inhibition and AMPK activation, accompanied by ROS accumulation and prolonged ER stress, to induce apoptosis.